2018 annual financial data

Rigel Pharmaceuticals 2018 Net margin

Rigel Pharmaceuticals 2018 net margin with verified reported values.

Direct answer

Net margin was -158.35%.

Operating income was -72,683,000 USD and net income was -70,480,000 USD.
Operating cash flow was -58,826,000 USD.

Get free Rigel Pharmaceuticals email updates.

Bullstory sends one daily email when new analysis or important company news is available.

Verified data

Revenue
44,509,000 USD
Operating income
-72,683,000 USD
Net income
-70,480,000 USD
Operating cash flow
-58,826,000 USD